Lexeo Therapeutics, Inc. · NASDAQ:LXEO
Montanova Capital, LLC reported a 7.70% stake in Lexeo Therapeutics, Inc. (Schedule 13G)
Event Apr 6, 2026 · Filed Apr 13, 2026
Montanova Capital, LLC reported a 7.70% stake in Lexeo Therapeutics, Inc., 5,674,778 shares, as a passive investor on Apr 6, 2026. Filed Apr 13, 2026 (Schedule 13G).
- Stake
- 7.70%
- Shares
- 5,674,778
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC | 7.70% | 5,674,778 |
| Averill Master Fund, Ltd. | 6.50% | 4,827,730 |
| AARON COWEN | 7.70% | 5,674,778 |
Source
Related
- Lexeo Therapeutics, Inc.
- Montanova Capital, LLC
- Lexeo Therapeutics, Inc. shareholders
- Schedule 13G · JPMorgan Chase & Co · Oct 13, 2026
- Form 4 · Bhalla Narinder Pal · Sep 28, 2026
- Form 4 · Otero Jose Manuel · Sep 28, 2026
- Form 4 · Townsend Richard Nolan · Sep 28, 2026
- Form 4 · Tamayo Louis Edward · Aug 19, 2026